CrossBridge aligns the interests of all stakeholders in the challenge of identifying and treating chronic inflammatory diseases – and assures much needed transparency in a healthcare system focused on Value-Based Care
Benefits to Patients, Window of Opportunity treatment, care coordination between primary physician and specialist, shared decision making, Benefits to Physicians and Practices, Decision support at clinical prescribing, Enhanced care coordination, Accountable Care Organizations, health plans, Payers, Self-Insured Employers
CrossBridge aligns the interests of all stakeholders in the challenge of identifying and treating chronic inflammatory diseases – and assures much needed transparency in a healthcare system focused on Value-Based Care.
Increased application of “Window of Opportunity” treatment and more efficient selection of appropriate treatment.
Enhanced care coordination between primary physician and specialist (rheumatologist, gastroenterologist, neurologist).
Treatment information for shared decision making.
Physicians and Practices
CrossBridge becomes a single, unbiased source of evidence-based treatments, supported by identified medical authorities and peer-reviewed literature … a robust value-based care solution – at no cost to the practice.
For each treatment option CrossBridge, prescribers can view cost, clinical benefits, side effects and outcomes targeted to stage of disease.
Increased probability of beginning proper treatment in the “Window of Opportunity”.
Maximum administration efficiency.
Equitable compensation in a Value-Based Care environment – transparent reimbursement.
Payers and Self-Insured Employers
All of the benefits to Patients and Payers manifest as better outcomes, justified reimbursements, and lower costs.
Absolute control over drug spend…one of the single-largest factors in the treatment of chronic inflammatory diseases.
Minimization of administrative costs/maximization of efficiency for payers and Third-Party Administrators (TPAs).